<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00997256</url>
  </required_header>
  <id_info>
    <org_study_id>PSC 152/04</org_study_id>
    <nct_id>NCT00997256</nct_id>
  </id_info>
  <brief_title>Study to Investigate Effects of a Herbal Drug Compared to Placebo on Sleep</brief_title>
  <acronym>sleep-EEG</acronym>
  <official_title>Phase I, Placebo-controlled, Double-blind, Randomised, Single-centre Study of Single Cross-over Design to Investigate the Effects of the Herbal Preparation Neurapas® Balance Compared With Placebo on Sleep EEG, Mental Performance and Well-being</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pascoe Pharmazeutische Praeparate GmbH</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pascoe Pharmazeutische Praeparate GmbH</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To demonstrate the influence of a herbal preparation containing hypericum, passionflower, and
      valerian on sleep structure, improvement of attention, and well-being in comparison to
      placebo.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To demonstrate the influence of the herbal combination preparation Neurapas® balance on the
      objective sleep structure in comparison with placebo. A further aim was to investigate
      whether treatment with Neurapas® balance versus placebo brings about an improvement in
      attention and well-being and whether these changes are related to the improvement in the
      sleep structure.

        1. Does the administration of 3 x 2 Neurapas® balance tablets over a period of three days
           vs. placebo lead to an improvement in continuity of sleep?

        2. Does the administration of 3 x 2 Neurapas® balance tablets over a period of three days
           vs. placebo lead to an improvement in sleep architecture, especially an increase in deep
           sleep?

        3. Does the administration of 3 x 2 Neurapas® balance tablets over a period of three days
           vs. placebo lead to an improvement in morning attentional performance?

        4. Does the administration of 3 x 2 Neurapas® balance tablets over a period of three days
           vs. placebo lead to an improvement in morning well-being?
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2004</start_date>
  <completion_date type="Actual">February 2005</completion_date>
  <primary_completion_date type="Actual">January 2005</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of sleep by Polysomnography (sleep continuity and sleep architecture)</measure>
    <time_frame>Day 3 + 14</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Attention Stress Test d2 (Brickenkamp)</measure>
    <time_frame>Day 4 + 15</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Alertness and vigilance test (TAP)</measure>
    <time_frame>Day 4 + 15</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Trail-Making Test (TMT)</measure>
    <time_frame>Day 4 + 15</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire on physical symptoms of subjective well-Being(MKSL, Janke)</measure>
    <time_frame>Day 4 +15</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire on psychological aspects of well-being(BSKE, Janke)</measure>
    <time_frame>Day 4 + 15</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ZERSSEN Scale of evaluation of subjective well-being (Bf-S)</measure>
    <time_frame>Day 4 + 15</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep Questionnaire(SF)</measure>
    <time_frame>Day 4 + 15</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Healthy</condition>
  <condition>Sleep Quality</condition>
  <arm_group>
    <arm_group_label>Verum</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Neurapas balance, film-coated tablets</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Film-coated sugar-pill</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Neurapas® balance (Herbal product (Hypericum, Passionflower, Valerian))</intervention_name>
    <description>3 x 2 tablets / day over 3 days</description>
    <arm_group_label>Verum</arm_group_label>
    <other_name>Neurapas balance, film-coated tablet over 3 days</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>film-coated sugar-pill</intervention_name>
    <description>3 x 2 tablets / day over 3 days</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy male volunteers aged between 18 and 55 years

          -  Normal sleeping times (at least 6 hours a night), going to sleep between 22.00 and
             1.00 hours, getting up between 6.00 and 9.00 hours

          -  Written informed consent

          -  The volunteer is willing and able to cooperate fully

          -  The volunteer agrees not to drink any alcohol for the duration of the study

        Exclusion Criteria:

          -  Participation in another study in the last 30 days or participation in this study at
             an earlier date

          -  Lack of verbal or intellectual ability to communicate adequately and to understand the
             information to volunteers

          -  Legal incompetence

          -  Smoker

          -  Shift worker

          -  Transatlantic flight in the last 4 weeks

          -  Taking psychotropic drugs within the last 4 weeks

          -  Taking medicines that influence the EEG within the last 4 weeks

          -  Diseases that influence the sleep EEG

          -  History of known medication / drug / alcohol misuse according to ICD-10 coding F10 -
             F19

          -  Known intolerance/hypersensitivity/allergy to St. John's wort, valerian or
             passionflower

          -  Taking inadmissible concomitant medication (anxiolytic, neuroleptic or hypnotic drugs,
             cyclosporin, sedative, sleep-promoting or mood-enhancing medicines, antidepressants
             other than the trial medication, coumarin-type anticoagulants, oral contraceptives,
             tranquillisers, homeopathic remedies, digoxin, theophylline, indinavir, nortriptyline,
             amitriptyline)

          -  Known light-sensitivity
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ulrich M Hemmeter, PD Dr Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Phillipps University Marburg, Clinic for Psychiatry and Psychotherapy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Phillipps University, Clinic for Psychiatry and Psychotherapy</name>
      <address>
        <city>Marburg</city>
        <state>Hesse</state>
        <zip>35039</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 16, 2009</study_first_submitted>
  <study_first_submitted_qc>October 16, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 19, 2009</study_first_posted>
  <last_update_submitted>May 14, 2010</last_update_submitted>
  <last_update_submitted_qc>May 14, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 17, 2010</last_update_posted>
  <responsible_party>
    <name_title>Anja Braschoss</name_title>
    <organization>Pascoe Pharmazeutische Preparate GmbH</organization>
  </responsible_party>
  <keyword>sleep-EEG</keyword>
  <keyword>sleep architecture</keyword>
  <keyword>sleep duration</keyword>
  <keyword>sleep continuity</keyword>
  <keyword>REM-sleep</keyword>
  <keyword>vigilance</keyword>
  <keyword>well-being</keyword>
  <keyword>Healthy volunteers</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

